Public source

Reviewed 4 Jun 2026

Completeness Fair (33%)

CellaVision® Bone Marrow Aspirate Application

CellaVision

The CellaVision® Bone Marrow Aspirate (BMA) Application automatically locates, captures, and pre-classifies cells based on morphology, enabling laboratories to automate morphological examination of bone marrow aspirate samples.

No papers to support — we monitor for new evidence.

General Information

Product name

CellaVision® Bone Marrow Aspirate Application

Modality

Cytopathology

Main task

Classification, Detection

Subspeciality

Hematopathology

Organ/Specimen source

Not specified

Disease targeted

Hematopoietic disorders

Specimen type

Smear(s)

Staining

Romanowsky

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Regulation (IVDR)

Class:

Class C

Verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

PDF

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

December 2025

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Apr 23, 2026 | Last updated: Jun 4, 2026